Your browser doesn't support javascript.
loading
The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates.
Al Kaabi, Nawal; Oulhaj, Abderrahim; Al Hosani, Farida Ismail; Al Mazrouei, Shamma; Najim, Omer; Hussein, Salah Eldin; Abdalla, Jehad Saleh; Fasihuddin, Mohammed Saifuddin; Hassan, Afnan Abdellatif; Elghazali, Gehad; Al Rumaithi, Ahmed; Al Azazi, Jumana; Weber, Stefan; Beiram, Rami; Parekh, Khatija A; Sheek-Hussein, Mohamud; Yang, Yunkai; Xiaoming, Yang; Quliang, Jenny; Eltantawy, Islam; Mahmoud, Sally; Koshy, Ashish; Xiao, Peng; Ganesan, Subhashini; Elamin, Wael; Zaher, Walid.
Afiliación
  • Al Kaabi N; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Oulhaj A; Department of Epidemiology and Public Health, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.
  • Al Hosani FI; Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.
  • Al Mazrouei S; Abu Dhabi Public Health Center - ADPHC, Abu Dhabi, UAE.
  • Najim O; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Hussein SE; Department of Health, Abu Dhabi, UAE.
  • Abdalla JS; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Fasihuddin MS; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Hassan AA; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Elghazali G; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Al Rumaithi A; Sheikh Khalifa Medical City-Union 71/Purehealth, Abu Dhabi, UAE.
  • Al Azazi J; College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.
  • Weber S; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Beiram R; Sheikh Khalifa Medical City SEHA, Abu Dhabi, UAE.
  • Parekh KA; Sheikh Khalifa Medical City-Union 71/Purehealth, Abu Dhabi, UAE.
  • Sheek-Hussein M; College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.
  • Yang Y; College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.
  • Xiaoming Y; College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, UAE.
  • Quliang J; China National Biotec Group Company Limited, Beijing, China.
  • Eltantawy I; China National Biotec Group Company Limited, Beijing, China.
  • Mahmoud S; China National Biotec Group Company Limited, Beijing, China.
  • Koshy A; G42 Healthcare, Masdar City, Abu Dhabi, UAE.
  • Xiao P; IROS (Insights Research Organization & Solutions), Masdar City, Abu Dhabi, UAE.
  • Ganesan S; G42 Healthcare, Masdar City, Abu Dhabi, UAE.
  • Elamin W; G42 Healthcare, Masdar City, Abu Dhabi, UAE.
  • Zaher W; G42 Healthcare, Masdar City, Abu Dhabi, UAE.
Sci Rep ; 12(1): 490, 2022 01 11.
Article en En | MEDLINE | ID: mdl-35017530
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas de Productos Inactivados / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas de Productos Inactivados / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article